Mycoplasma genitalium macrolide resistance update: Rate among a 2016-2017 cohort of patients in Barcelona, Spain.

[1]  G. Cilla,et al.  Guided antibiotic therapy for Mycoplasma genitalium infections: Analysis of mutations associated with resistance to macrolides and fluoroquinolones , 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

[2]  S. Garland,et al.  Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  N. Jeoffreys,et al.  Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney , 2018, Sexually Transmitted Infections.

[4]  J. Jensen,et al.  Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013–2014 Cohort of Patients in Barcelona, Spain , 2017, Sexually transmitted diseases.

[5]  J. Jensen.  Mycoplasma genitalium: yet another challenging STI. , 2017, The Lancet. Infectious diseases.

[6]  C. Bradshaw,et al.  New Horizons in Mycoplasma genitalium Treatment , 2017, The Journal of infectious diseases.

[7]  S. Garland,et al.  Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium , 2017, Emerging infectious diseases.

[8]  J. G. Kusters,et al.  Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides. , 2017, Enfermedades infecciosas y microbiologia clinica.

[9]  M. Cusini,et al.  Background review for the 2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  A. Thürmer,et al.  Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany. , 2016, Diagnostic microbiology and infectious disease.

[11]  S. Pereyre,et al.  Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France , 2016, Emerging infectious diseases.

[12]  J. Jensen,et al.  Mycoplasma genitalium macrolide resistance in Stockholm, Sweden , 2016, Sexually Transmitted Infections.

[13]  D. Getman,et al.  Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States , 2016, Journal of Clinical Microbiology.

[14]  S. Garland,et al.  Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology , 2016, PloS one.

[15]  W. I. van der Meijden,et al.  2016 European guideline on the management of non-gonococcal urethritis , 2016, International journal of STD & AIDS.

[16]  J. Hocking,et al.  The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. Yasuda,et al.  Drug Resistance – Associated Mutations in Mycoplasma genitalium in Female Sex Workers , 2019 .

[18]  A. Rowhani-Rahbar,et al.  Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Jensen,et al.  Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Jensen,et al.  Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic , 2013, PloS one.

[21]  Navneet R. Hakhu,et al.  Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  S. Pereyre,et al.  Detection of macrolide resistance in Mycoplasma genitalium in France. , 2012, The Journal of antimicrobial chemotherapy.

[23]  D. Taylor-Robinson,et al.  Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly , 2011, Clinical Microbiology Reviews.

[24]  M. Yasuda,et al.  Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin , 2011, Sexually Transmitted Infections.

[25]  T. Mroczkowski,et al.  A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  S. Tabrizi,et al.  Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Garland,et al.  Azithromycin Failure in Mycoplasma genitalium Urethritis , 2006, Emerging infectious diseases.

[28]  T. Deguchi,et al.  Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. , 2001, The Journal of antimicrobial chemotherapy.

[29]  J. Vuust,et al.  Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples , 1991, Journal of clinical microbiology.

[30]  J. Tully,et al.  A NEWLY DISCOVERED MYCOPLASMA IN THE HUMAN UROGENITAL TRACT , 1981, The Lancet.

[31]  J. Navarro-Marí,et al.  Mycoplasma genitalium: Using a commercial molecular technique that facilitates rapid detection of mutations associated with resistance to macrolides. , 2019, Enfermedades infecciosas y microbiologia clinica.

[32]  D. Gesink,et al.  Mycoplasma genitalium presence, resistance and epidemiology in Greenland. , 2012, International journal of circumpolar health.